Ginseng-Cistanche Composition for ALS Progression and Muscle Weakness

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for amyotrophic lateral sclerosis (ALS) lack effective drugs with minimal side effects and fail to address the underlying pathogenesis of the disease, primarily involving motor neuron degeneration and muscle weakness, leading to a high economic burden and quality of life issues for patients.

Innovation Solution

A traditional Chinese medicine composition comprising Ginseng Radix et Rhizoma and Cistanche deserticola is formulated to address the deficiency of genuine primordial qi and nourish the governor vessel, targeting the root cause of ALS by reinforcing Yuan-primordial qi and nourishing nutrient qi to support muscles, using herbs that supplement Yang and Yin to relieve flaccidity and improve muscle function.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional Western medicine treatments (riluzole, edaravone) are used for ALS, then some therapeutic effects are achieved, but side effects occur and treatment costs are high

Engineering Contradiction:
Improvetherapeutic effectVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the fundamental treatment parameter from Western medicine's glutamate inhibition and free radical scavenging to Traditional Chinese Medicine's qi and blood regulation. By using Ginseng Radix et Rhizoma and Cistanche deserticola, the treatment shifts from targeting specific pathological mechanisms to regulating the body's overall energy and substance balance, thereby achieving therapeutic effects without the harsh side effects of conventional drugs.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent combines two traditional Chinese medicine materials - Ginseng Radix et Rhizoma (for supplementing qi) and Cistanche deserticola (for nourishing blood and Yin). This composite approach creates a synergistic effect where the two materials work together to address both the qi deficiency and blood deficiency aspects of ALS, providing comprehensive treatment without the side effects associated with single Western medicine agents.

Inventive Principle:
Principle #40Composite materials

2Reliability

If conventional Western medicine treatments are used for ALS, then some therapeutic effects are achieved, but treatment costs are significantly high

Engineering Contradiction:
Improvetherapeutic effectVSAvoidtreatment cost
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The patent employs traditional Chinese medicine materials that are more accessible and cost-effective compared to expensive Western medicine treatments like edaravone infusion. Ginseng and Cistanche can be administered orally in various dosage forms (decoctions, pills, capsules), eliminating the need for expensive hospital infrastructure and continuous intravenous therapy, thereby significantly reducing treatment costs while maintaining therapeutic efficacy.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Duration of action of stationary object

If early diagnosis and treatment of ALS are pursued, then patient survival period can be extended, but diagnostic difficulty leads to high rates of misdiagnosis and missed diagnosis

Engineering Contradiction:
Improvesurvival periodVSAvoiddiagnostic accuracy
Core Design Contradiction:
Duration of action of stationary objectVSDifficulty of detecting and measuring

Solution Approach 1:

The patent adopts a treatment approach that does not rely heavily on precise early diagnosis. By using Traditional Chinese Medicine's pattern differentiation (bian zheng) based on clinical symptoms like muscle weakness, atrophy, and fasciculation, the treatment can be initiated based on syndrome identification rather than definitive ALS diagnosis. This allows treatment to begin earlier without requiring complex diagnostic procedures, thereby extending survival period while avoiding the pitfalls of misdiagnosis.

Inventive Principle:
Principle #25Self-service

4Duration of action of stationary object

If disease progression is allowed to continue, then natural disease course follows, but muscle weakness and atrophy lead to loss of self-care ability and heavy burden on families

Engineering Contradiction:
Improvedisease courseVSAvoidself-care ability
Core Design Contradiction:
Duration of action of stationary objectVSEase of operation

Solution Approach 1:

The patent implements preliminary action by intervening early in the disease course using Traditional Chinese Medicine. By addressing qi deficiency and blood deficiency at the initial stages through Ginseng and Cistanche treatment, the disease progression is slowed before severe muscle atrophy and loss of self-care ability occur. This preliminary intervention prevents the deterioration that would otherwise lead to complete dependence on others.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentEP4674423A1Traditional chinese medicine composition for treating amyotrophic lateral sclerosis and use thereof
Publication Date: 2026.01.07 HEBEI YILING MEDICINE INST
  • EP4674423A1 patent drawingFigure 1
  • EP4674423A1 patent drawingFigure 2
  • EP4674423A1 patent drawingFigure 3

AI summary

A traditional Chinese medicine composition for treating amyotrophic lateral sclerosis and the use thereof. The composition is prepared by means of combining Ginseng radix et rhizoma and Cistanches herba.